TLR4 and necrotizing enterocolitis: To this end, our group identified a novel family of NEC therapeutics that target TLR4 and that have been shown to prevent NEC in the hypoxia/formula gavage/bacteria NEC mouse model (Neal et al., 2013b; Wipf et al., 2015).